Raymond James Financial Inc. Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Raymond James Financial Inc. acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 492,046 shares of the company’s stock, valued at approximately $6,613,000. Raymond James Financial Inc. owned 0.20% of Oscar Health at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp grew its position in shares of Oscar Health by 6.0% in the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after acquiring an additional 291,335 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock worth $92,062,000 after buying an additional 455,205 shares during the period. Hennessy Advisors Inc. boosted its holdings in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after buying an additional 938,742 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Oscar Health by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,862 shares of the company’s stock worth $22,241,000 after buying an additional 54,696 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

NYSE OSCR opened at $13.06 on Monday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.27 billion, a P/E ratio of -652.42 and a beta of 1.75. Oscar Health, Inc. has a 12-month low of $12.43 and a 12-month high of $23.79. The firm has a 50-day moving average price of $15.04 and a two-hundred day moving average price of $16.20.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently commented on OSCR. Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Jefferies Financial Group began coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.